Overview Request Sample Pages Request Customization Download PDF
You are viewing: Rest Of Europe Digital Pathology Market analysis
Part of: Digital Pathology Market (Global)

The Rest Of Europe Digital Pathology Market was valued at $83.3 Million in 2026 and projected to reach to $133.7 Million by 2031, representing a compound annual growth rate of 9.9%. Rest Of Europe's digital pathology market is positioned for sustained expansion through 2031, driven by healthcare modernization initiatives and increasing investment in diagnostic infrastructure.

Rest Of Europe Digital Pathology Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Digital Pathology Market Trends and Insights

  • This 9.9% compound annual growth rate reflects increasing adoption of digital diagnostic solutions across the region's healthcare systems.
  • Rest Of Europe is benefiting from regulatory harmonization, rising demand for remote pathology services, and investments in laboratory automation that align with broader European healthcare modernization initiatives. The market in Rest Of Europe is driven by aging populations requiring advanced diagnostic capabilities and healthcare providers seeking operational efficiency.
  • Rest Of Europe's pathology labs are transitioning from traditional microscopy to whole-slide imaging and AI-assisted analysis platforms.
  • Between 2026 and 2031, Rest Of Europe will see accelerated deployment of digital pathology infrastructure, supported by government healthcare funding and private sector innovation in medical imaging technology..

Key Market Statistics

  • CAGR (2026-2031) 9.9% CAGR
  • Market Size, 2026 ~USD 83.3 Million
  • Forecast, 2031 ~USD 133.7 Million
  • Country Rest Of Europe

Rest Of Europe Digital Pathology Market Overview

Market Valuation Growth :

Rest Of Europe's digital pathology market is valued at $83.3 million in 2026 and is projected to reach $133.7 million by 2031, representing a robust 60.5% total growth over the forecast period.

Steady CAGR Performance :

The region demonstrates a consistent 9.9% compound annual growth rate, outpacing many mature European markets and reflecting strong adoption of digital diagnostic infrastructure across healthcare systems.

Regulatory Harmonization Benefits :

Rest Of Europe is capitalizing on EU regulatory alignment and standardization efforts, which streamline digital pathology implementation and accelerate cross-border adoption of diagnostic solutions.

Remote Pathology Demand Surge :

Increasing demand for remote pathology services is driving market expansion, particularly in countries with dispersed populations and limited specialist availability, enhancing diagnostic accessibility across the region.

Rest Of Europe Digital Pathology Market Dynamics

  • The region's adoption of digital solutions is accelerating as healthcare providers seek to improve operational efficiency, reduce turnaround times, and enhance diagnostic accuracy.
  • Regulatory harmonization across EU member states is facilitating market entry and standardization of digital pathology platforms. The forecast period will see growing integration of artificial intelligence and machine learning capabilities within digital pathology systems across Rest Of Europe.
  • Healthcare systems are increasingly recognizing the value of remote consultation capabilities and centralized diagnostic services, particularly in smaller nations with limited specialist resources.
  • This trend, combined with rising healthcare expenditure and digital transformation initiatives, positions Rest Of Europe as a high-growth segment within the broader European digital pathology landscape..

Related Ecosystem

Healthcare Analytics

Top Technologies
    Top Companies

      Healthcare It

      Top Technologies
        Top Companies

          Key Takeaways

          • Rest Of Europe's digital pathology market will grow from $83.3M (2026) to $133.7M (2031) at a 9.9% CAGR.
          • Rest Of Europe is adopting whole-slide imaging and AI-assisted diagnostic tools to modernize laboratory workflows.
          • Rest Of Europe benefits from regulatory alignment and cross-border healthcare collaboration within the European framework.
          • Rest Of Europe's market growth is supported by aging demographics and increased demand for remote pathology services.

          Digital Pathology Market Report Scope

          Report Metric Details
          Base Year 2026
          Fastest Growing Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
          Forecast Period 2026–2031
          Growth Rate CAGR of 12.5% from 2026 to 2031
          Largest Segment ONCOLOGY (Therapeutic Area)
          Market Size Base Year (Billions) ~USD 1.59 (2026)
          Revenue Forecast (Billions) ~USD 2.86 (2031)
          Segments Covered Product, Type, Technology, Application, Therapeutic Area, End User

          Rest Of Europe Digital Pathology Market Report Segmentation

          6 segment dimensions are covered across the global market.

          By Product

          • Hardware
          • Software
          • Storage Systems

          By Type

          • AI & Computational Pathology Software
          • Biomarker Discovery & Validation
          • Brightfield Scanners
          • Cloud Storage
          • Drug Discovery & Efficacy Studies
          • Enterprise Digital Pathology Solutions/Platforms
          • Fluorescence Scanners
          • Human Pathology
          • Hybrid Storage
          • Image Analysis Software
          • Image Management Software
          • On-Premise Storage
          • Other Pre-Clinical Research
          • Other Scanners
          • Peripherals & Accessories
          • Toxicology & Safety Assessment
          • Veterinary Pathology
          • Whole Slide Imaging Scanners
          • Workstations & Viewing Systems

          By Technology

          • AI-Enabled Digital Pathology
          • Conventional Digital Pathology

          By Application

          • Academic & Translational Research
          • Clinical Diagnostics
          • Clinical Trials
          • Education & Training
          • Other Applications
          • Pre-Clinical Research
          • Telepathology

          By Therapeutic Area

          • Gastrointestinal Disease
          • Hematology
          • Infectious Disease
          • Neurology
          • Oncology
          • Other Therapeutic Areas

          By End User

          • Academic & Research Institutes
          • Contract Research Organizations
          • Diagnostic & Reference Laboratories
          • Hospitals & Health Systems
          • Other End Users
          • Pharmaceutical & Biotechnology Companies
          • Veterinary Laboratories

          Target Audience

          • Digital Pathology Solution Providers : Vendors and technology companies need Rest Of Europe market data to identify regional demand patterns, competitive landscape, and growth opportunities for platform deployment and customer acquisition in this high-growth segment.
          • Healthcare System Administrators : Hospital networks and diagnostic centers across Rest Of Europe require market insights to justify digital pathology investments, benchmark against regional peers, and plan infrastructure modernization initiatives aligned with market trends.
          • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities in Rest Of Europe need regional market sizing and growth forecasts to assess portfolio companies, identify acquisition targets, and evaluate market entry strategies.
          • Medical Device & Diagnostics Manufacturers : Companies developing pathology equipment and diagnostic solutions require Rest Of Europe-specific market data to prioritize regional product launches, allocate R&D resources, and develop localized commercialization strategies.
          • Healthcare Consultants & Analysts : Consulting firms and research organizations advising healthcare clients in Rest Of Europe need accurate regional market data to support strategic recommendations, feasibility studies, and digital transformation roadmap development.

          Key Companies in the Rest Of Europe Digital Pathology Market

          CompanyHQOwnershipStrongest segments
          NIKON CORPORATIONJapanPublic CompanyImaging Business (digital cameras and cinema cameras),Precision Equipment Business (FPD exposure equipment),Healthcare Business (life science solutions),
          PIXCELLDATAIsraelPrivate CompanyCore data/analytics platform subscriptions,Professional services & implementation,Value-added modules & advanced analytics,
          SUNQUEST INFORMATION SYSTEMSUnited StatesPrivate CompanyCore LIS (Sunquest Laboratory, Multi-Lab Networking, Collect),Pathology and Anatomic Pathology (PowerPath, CoPathPlus),Blood Bank and Transfusion Management,
          CERNER CORPORATIONUnited StatesPrivate CompanyCerner Millennium and core clinical/financial applications,HealtheIntent population health and data platform,CareAware and device connectivity solutions,
          ZENSAR TECHNOLOGIES LTDIndiaPublic CompanyDigital and Application Services,Cloud Infrastructure and Security,Experience, Brand, and Creative Services,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, cell culture, filtration),Life Sciences (genomics, mass spec, imaging, lab automation),Diagnostics (clinical instruments, consumables, software),
          KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
          SECTRA ABSwedenPublic CompanyImaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, precision diagnostics),
          HAMAMATSU PHOTONICS K.K.JapanPublic CompanyElectron Tube (incl. photomultiplier tubes and radiation/x-ray sensors),Opto-Semiconductor (photodiodes, APDs, SPADs, MPPC, UV/IR sensors),Imaging and Measurement Instruments (cameras, spectrometers, x-ray systems, software),
          QUANTERIX CORPORATIONUnited StatesPublic CompanyHD-X instrument and related assays/consumables,SR-X instrument and related assays/consumables,SP-X planar array platform and multiplex assays,
          FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics),Business Innovation (office, document solutions, graphic communications),Electronics (display, semiconductor materials, storage, industrial equipment),
          HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, Rapid Fetal Fibronectin),Breast Health (3D mammography, biopsy, localization, treatment support),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
          AIFORIAFinlandPublic CompanyClinical AI suite (viewer + cancer diagnostics),Aiforia Create (AI model development platform),Services, customization, and other software,

          NIKON CORPORATION

          Nikon Corporation is a Japanese public company founded in 1917 with 19,928 employees, known for manufacturing imaging and optical products.

          PIXCELLDATA

          Pixcelldata is a private company founded in 2010 and based in Israel.

          SUNQUEST INFORMATION SYSTEMS

          Sunquest Information Systems is a private company founded in 1979 and based in the United States.

          CERNER CORPORATION

          Cerner Corporation is a private company founded in 1979 in the United States with 25,150 employees, specializing in healthcare information technology.

          ZENSAR TECHNOLOGIES LTD

          Zensar Technologies Ltd is an Indian public company founded in 1963 with 10,066 employees, providing IT services and solutions.

          DANAHER CORPORATION

          Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees, operating as a diversified conglomerate.

          KONINKLIJKE PHILIPS N.V.

          Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees, operating as a global diversified technology corporation.

          SECTRA AB

          Sectra AB is a Swedish public company founded in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

          HAMAMATSU PHOTONICS K.K.

          Hamamatsu Photonics K.K. is a Japanese public company founded in 1953 with 6,601 employees, manufacturing photonic products and systems.

          QUANTERIX CORPORATION

          Quanterix Corporation is a public company founded in 2007 in the United States with 450 employees, specializing in biotech instrumentation.

          FUJIFILM HOLDINGS CORPORATION

          Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, operating across imaging, healthcare, and materials sectors.

          HOLOGIC, INC.

          Hologic, Inc. is a private company founded in 1985 in the United States with 7,070 employees, specializing in medical diagnostics and imaging.

          AIFORIA

          Aiforia is a Finnish public company founded in 2013 with 76 employees, specializing in artificial intelligence solutions.

          Reasons to Buy this Report

          • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Europe, including 2026 baseline ($83.3M) and 2031 projections ($133.7M), enabling accurate budget allocation and investment planning for regional expansion strategies.
          • Growth Trajectory Analysis : Understand the 9.9% CAGR dynamics unique to Rest Of Europe, identifying which sub-segments and countries within the region are driving growth and where competitive opportunities exist for market entry or expansion.
          • Regulatory & Adoption Insights : Gain intelligence on EU regulatory harmonization impacts, remote pathology service adoption patterns, and healthcare system modernization initiatives specific to Rest Of Europe that influence market dynamics and implementation timelines.
          • Competitive Positioning Strategy : Benchmark your organization against regional market trends and identify gaps in digital pathology adoption across Rest Of Europe, enabling targeted go-to-market strategies and partnership opportunities with healthcare providers.
          • Investment Decision Support : Make informed investment and resource allocation decisions based on Rest Of Europe-specific market data, growth forecasts, and regional healthcare spending patterns to maximize ROI in this emerging digital pathology segment.

          Frequently asked questions

          What is the market size of digital pathology in Rest Of Europe?

          Rest Of Europe's digital pathology market was valued at $83.3 million in 2026 and is forecast to reach $133.7 million by 2031.

          What is the growth rate for digital pathology in Rest Of Europe?

          Rest Of Europe's digital pathology market is expected to grow at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2031.

          What are the main drivers of digital pathology adoption in Rest Of Europe?

          Rest Of Europe's adoption is driven by aging populations, demand for remote diagnostic services, laboratory automation investments, and regulatory harmonization across European healthcare systems.

          Which technologies are transforming pathology in Rest Of Europe?

          Rest Of Europe is seeing rapid deployment of whole-slide imaging systems, AI-assisted diagnostic platforms, and cloud-based pathology solutions that improve efficiency and diagnostic accuracy.

          How does Rest Of Europe compare to other European markets?

          Rest Of Europe represents a significant portion of the broader European digital pathology market, with growth rates reflecting regional healthcare modernization efforts and varying levels of digital infrastructure investment.

          RESEARCH METHODOLOGY

          This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

          Secondary Research

          This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital pathology market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

          Primary Research

          In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital pathology market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and academic & research institutes.

          Digital Pathology Market Size, and Share

          *Others include sales managers, marketing managers, and product managers.

          Note: Tiers are defined based on a company’s total revenue as of 2025: Tier 1 = > USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          The total size of the digital pathology market was determined through data triangulation using the two approaches described below. After completing each approach, a weighted average was calculated based on the level of assumptions used in each approach.

          Digital Pathology Market Top Down and Bottom Up Approach

          Data Triangulation

          The size of the digital pathology market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows: -

          • Revenues for individual companies were gathered from public sources and databases.
          • Shares of leading players in the digital pathology market were gathered from secondary sources to the extent available. In certain cases, shares of digital pathology businesses have been determined through a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach & strength. 
          • Individual shares or revenue estimates were validated through interviews with experts.
          • The total revenue in the digital pathology market was determined by extrapolating the market share data of major companies.

          Market Definition

          Digital pathology is an image-based information environment for managing and interpreting information generated from digitized glass slides. The process involves converting glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, enabling high-resolution slide viewing.

          Key Stakeholders

          • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Ambulatory Centers, and Outpatient Clinics)
          • Digital Pathology Organizations
          • Senior Management
          • Finance/Procurement Department
          • R&D Department
          • Healthcare Data Aggregators
          • Venture Capitalists
          • Government Agencies
          • Healthcare Startups, Consultants, and Regulators
          • Academic Medical Institutes

          Report Objectives

          • To define, describe, and forecast the digital pathology market based on product, type, technology, application, therapeutic area, end user, and region
          • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
          • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
          • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
          • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
          • To profile the key players and analyze their market shares and core competencies2
          • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital pathology market
          • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

          Available customizations:

          With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 5)

          Geographic Analysis

          • Further breakdown of the Rest of Asia Pacific digital pathology market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
          • Further breakdown of the Rest of Europe digital pathology market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

           

          Get the Full Digital Pathology Market Report

          Full forecast, segment splits, and company analysis for all Digital Pathology Market.

          Download Sample Pages Buy Report

          METHODOLOGY

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          Cite this Research
          DMCA.com Protection Status